Ordinary Adjustment | Solactive Longevity Innovators Index | Effective Date 15th October 2026

October 2, 2026

Announcement

Ordinary Adjustment | Solactive Longevity Innovators Index | Effective Date 15th October 2026

Solactive Longevity Innovators Index:

In the ordinary adjustment, the following composition will be implemented effective open 15th October 2026:

ABBOTT LABORATORIES
BEAM THERAPEUTICS INC
BECTON DICKINSON AND CO
BELLRING BRANDS INC
CRISPR THERAPEUTICS AG
DSM FIRMENICH AG
GE HEALTHCARE TECHNOLOGIES INC
GLANBIA PLC
HERBALIFE LTD
HIMS & HERS HEALTH INC
INTELLIA THERAPEUTICS INC
INTUITIVE SURGICAL INC
KONINKLIJKE PHILIPS NV
LANTHEUS HOLDINGS INC
LUMEXA IMAGING HOLDINGS INC
MEDTRONIC PLC
MODERNA INC
Praxis Precision Medicines Inc
RADNET INC
STRYKER CORP
TELADOC HEALTH INC
TELIX PHARMACEUTICALS LTD
TEMPUS AI INC
VERTEX PHARMACEUTICALS INC
ZIMMER BIOMET HOLDINGS INC
Index nameRICISIN
Solactive Longevity Innovators Index PR.SOLLOINPDE000SL0SLS5
Solactive Longevity Innovators Index NTR.SOLLOINNDE000SL0SLT3
Solactive Longevity Innovators Index TR.SOLLOINTDE000SL0SLU1

Share your view and thoughts

We work closely with our internal partners to deliver investment ideas that generate demonstrable value for our clients.